Cathetrix is continuing its international expansion with advanced negotiations underway with K77 Trade for the distribution of its catheter solutions in Canada. As part of this process, K77 Trade, located in Montreal, Quebec, is actively evaluating the potential of Foley-Safe, with early feedback from several local hospitals indicating strong interest and positive clinical impressions.
Canada presents a strong commercial opportunity in urinary care. The country’s healthcare system serves a growing and aging population, where the prevalence of conditions affecting urinary function continues to rise. According to a report by Grand View Research, the Canadian urinary catheter market was valued at approximately $237 million in 2024 and is expected to grow steadily, driven by demand for long-term care solutions and improved patient management.
At the same time, the market is undergoing a clear structural shift. An April 2026 analysis by IndexBox highlights a move from volume-based procurement to value-driven purchasing, with a strong focus on safety and clinical outcomes.
A key priority is the reduction of catheter-associated urinary tract infections (CAUTIs), which account for up to 40 percent of hospital-acquired infections in many healthcare systems. This is pushing hospitals to prioritize solutions that can improve stability, reduce complications, and deliver measurable clinical value.
Another important trend is the rapid expansion of home care. Chronic urinary management is increasingly shifting beyond hospital settings, creating demand for intuitive, patient-friendly solutions that support safe self-management. This shift is also influencing purchasing decisions, with greater emphasis on ease of use, training, and reliable supply.
Within this evolving landscape, Foley catheters remain a cornerstone of urological care. Healthcare providers are placing greater emphasis on reducing complications, improving patient comfort, and ensuring consistent performance across care settings.
K77 Trade brings strong local market knowledge and commercial capabilities, positioning it as an effective distribution partner for Cathetrix. Its ongoing engagement with hospitals is already validating product-market fit and supporting future commercialization.
As part of its market entry strategy, Cathetrix is preparing to navigate the regulatory framework governed by Health Canada, ensuring compliance with strict safety and performance standards. Foley-Safe is a key part of Cathetrix’s offering.
Designed to improve the stability and safety of indwelling catheter use, it helps reduce unwanted movement and traction, which may lower the risk of urethral irritation and related complications. Its user-friendly design supports both hospital and home-care environments, aligning with the shift toward patient-centered care.
As part of its broader North America expansion, Cathetrix will be exhibiting at the World Health Expo (WHX) Miami 2026, taking place June 17-19, 2026, in Miami, Florida. Visitors are invited to meet the team at booth Y106 in the Future-X zone.